respiratory region of the lung is a common occurrence; however, RAGE-mediated mechanisms of basement membrane and other matrix destruction have not been described. Methods and results: While Safrin-O/Fast Green and Serious Red staining revealed indistinguishable differences in total collagen abundance between RAGE overexpressing and wild type mice, immunohistochemistry for collagen type IV revealed sporadic expression in both groups. Quantification of collagen type IV by immunoblotting revealed a significant decrease of collagen type IV in RAGE transgenic mice compared to wild type controls. Immunostaining and immunoblotting further revealed increased MMP-9 expression in the RAGE transgenic mouse while MMP-13 expression was not significantly altered. Conclusions: The data presented suggest that RAGE overexpression weakens the basement membrane and associated matrix via increased MMP-9 activity. Ongoing research may identify additional information relating to RAGE-mediated signaling that contributes to inflammation at the respiratory membrane. Connective tissue growth factor (CTGF) is a secreted protein that functions in angiogenesis, cellular migration, and tumor growth. Recent studies have shown that CTGF is up-regulated during pregnancy and lactation in the cow and mouse and may be needed during differentiation of the mammary epithelial cell. CTGF has been shown to be up-regulated in breast cancer cell lines, and may be a marker for metastasis cancer. The function of CTGF and its location during early embryonic mammary gland development remains unknown. Previous research has demonstrated that parathyroid hormone related protein (PTHrP) is a secreted protein from mammary epithelial cells and is required for cell fate specification of mammary epithelial cells and outgrowth. Canonical Wnt signaling is required for formation of the mammary bud, and that the loss of canonical Wnt signaling prevents formation of the mammary gland. In this study, we characterize regulation and localization of CTGF during embryonic mammary gland development. To do this, we acquired a transgenic mouse where b-galactosidase was inserted into the CTGF gene. Therefore, staining mice with X-gal, enables us to examine localization and regulation of CTGF in the whole mouse. Embryos from embryonic day (E) 11.5, E13.5, E15.5, E16.5, and E18.5 were harvested from a cross between CD1 female and CTGF +/− male mice. Embryos were stained with X-gal and examined for bgalactosidase in both the whole animal and by histological sectioning through the mammary bud structures. Within CTGF +/− E11.5 mice, there was no staining in the vicinity of the mammary milk line. Migrating cells from possibly the somites and spinal cord were seen moving ventrally and expressing b-galactosidase. In E13.5 and E15.5 female CTGF +/− embryos, b-galactosidase was seen deep to the mammary buds, and in the hair follicle buds, but not in the mammary bud itself. In E15.5 male embryos, b-galactosidase staining was prevalent in the mammary buds, most likely because of the cell fate change due to androgen induction. At E16.5, we observed a decrease in b-galactosidase staining throughout the embryo (hair follicles and around the mammary buds), and by E18.5, embryos had very little CTGF expression in the skin structures, as seen by the reduction in b-galactosidase expression. NMuMG cells were treated overnight with PTHrP (10-7 M) and CTGF RNA expression was examined over a period of 4 days using real time PCR. No apparent effect of PTHrP on CTGF in NMuMG cells was observed. To examine whether canonical Wnt signaling effects CTGF expression, cells were treated with lithium chloride (5-50 mM) over a series of 4 days, and CTGF expression was measured using real-time PCR. Cells treated with LiCl did not change RNA levels of CTGF expression. Since CTGF is expressed in cells deep to the mammary bud, it may suggest that CTGF expression induces or guides the outgrowth of the mammary bud, or that it is involved in the induction of the mammary fat pad. Regulation of CTGF may occur through other pathways, such as hedgehog or TNF-a signaling, both of which have been demonstrated to function during mammary gland development. Further research will examine these possibilities. Connective tissue growth factor (CTGF) is a secreted protein found in the extracellular matrix. It is a multifunctional protein with the capability to bind to and sequester growth factors, such as TGF-b, and BMPs. It has also been demonstrated to function during angiogenesis and cell migration. Recent studies on CTGF in both the cow and mouse have demonstrated that CTGF is needed for differentiation of the mammary epithelial cells, and has increased expression during pregnancy and lactation. In this study we characterized the location of CTGF in the adult mammary gland, determined the cell type expressing CTGF and how CTGF is regulated. Transgenic mice containing one CTGF allele interrupted with the b-galactosidase gene were examined at day 7, 5-week virgin, 12-week virgin, midpregnant, mid-lactation, and 2-and 7-day involution mice. Mammary glands were harvested and stained for β-galactosidase and counterstained with carmine alum. CTGF expression was not seen in adipocytes of the mammary fat pad, but did appear to be in some cells of the mammary ducts. Further examination of these cells suggests that these are myoepithelial cells. The endothelial cells of blood vessels, which have been previously identified as a site of CTGF expression, were found to have very strong b-galactosidase expression. To determine whether the loss of CTGF affected branching morphogenesis in the mammary glands, mice from 5-week-old virgin wild-types and CTGF+/− mice were harvested and the mammary glands were stained with carmine alum. Primary and secondary mammary ducts were measured and a significant decrease in branching (p < 0.05) in the CTGF+/− mice was observed. This suggests that CTGF plays a role during branch morphogenesis during mammary gland development. Since several studies suggested that mammary epithelial cells may express CTGF, we used the NMuMG cell line to examine regulation of CTGF. TGF-b has been shown to be involved in mammary gland morphogenesis, and in other cell types has been shown to regulate CTGF expression. Cells were treated with TGF-b (1-10 ng/ml) over a period of 4 days and CTGF RNA expression was examined using real time PCR. Contrary to other studies, TGF-b did not affect CTGF expression in the NMuMG cells. Further research will examine the role CTGF has on myoepithelial cell differentiation and regulation. 
